PsyMed Ventures (@psymedventures) 's Twitter Profile
PsyMed Ventures

@psymedventures

We invest in frontier tech in mental and brain health. Tune into our podcast Business Trip (businesstrip.fm)

ID: 1415084941721804804

linkhttp://psymed.ventures calendar_today13-07-2021 23:05:20

245 Tweet

1,1K Followers

5 Following

PsyMed Ventures (@psymedventures) 's Twitter Profile Photo

Autism rates have risen dramatically in recent decades, far outpacing what could be explained by genetic changes alone. Elizabeth Horn of the 2m Foundation shares environmental triggers that could be playing a significant role.

PsyMed Ventures (@psymedventures) 's Twitter Profile Photo

Temporal Interference (TI) stimulation is a non-invasive neuromodulation technique that uses high-frequency electrical fields to selectively stimulate deep brain regions without affecting surrounding tissue. Listen to the full episode here: businesstrip.fm/podcast/episod…

PsyMed Ventures (@psymedventures) 's Twitter Profile Photo

Neuromodulation techniques have shown potential for improving memory, but developing reliable, science-backed interventions remains a significant challenge. Listen to the full episode here: businesstrip.fm/podcast/episod…

Greg Kubin (@kubeans) 's Twitter Profile Photo

New Business Trip episode! We introduce our new partner Brooks, explore our favorite frontier investable areas in brain health, and discuss our next fund. businesstrip.fm/podcast/episod…

PsyMed Ventures (@psymedventures) 's Twitter Profile Photo

PsyMed Ventures Partner Brooks Leitner shares why there are opportunities to build in consumer health and how innovation is not limited to medical products. Listen to the full episode on the Business Trip podcast: businesstrip.fm/podcast/episod…

Greg Kubin (@kubeans) 's Twitter Profile Photo

NYC: Join us April 1 for Night of Neurotech—a Deep Tech Week NY event on breakthroughs in neuroscience and BCIs. RSVP: lnkd.in/ekKJHxcv Big ideas, a brainy crowd, and the future of neurotech—all in one night.

NYC: Join us April 1 for Night of Neurotech—a Deep Tech Week NY event on breakthroughs in neuroscience and BCIs. 

RSVP: lnkd.in/ekKJHxcv 

Big ideas, a brainy crowd, and the future of neurotech—all in one night.
Caitlin Ner 🇵🇭☁️ (@caitlinner) 's Twitter Profile Photo

🚀 Join us at NY Deep Tech Week! PsyMed Ventures is hosting a night of neurotech breakthroughs & BCI innovation with top founders, researchers & investors. Don’t miss this chance to connect & explore the future of brain tech! 🧠 RSVP here: lu.ma/dtw-neurotech?…

Matias Serebrinsky (@matisere) 's Twitter Profile Photo

New epi: What's wrong with US healthcare and how startups can fix it - w/ Justin Mares A while back Daisy Wolf wrote that the biggest company in the world will be a consumer health tech company. I agree, Justin agrees. But it hasn't happened yet. Why? Among other things, the

PsyMed Ventures (@psymedventures) 's Twitter Profile Photo

We’re seeing a massive shift in healthcare from doctor-centered care to consumer-driven, AI-supported care according to Justin Mares in the latest Business Trip episode. Listen to the full episode here: businesstrip.fm/podcast/episod…

Matias Serebrinsky (@matisere) 's Twitter Profile Photo

We’re co-hosting Night of Neurotech at SF Deep Tech Week with E11 Bio! This year we're featuring founders & scientists exploring far-future neuroscience tech for human augmentation. Neuroscience isn't just for healing; it will elevate everyone's lives. June 24th, 5-8pm Sign up:

Matias Serebrinsky (@matisere) 's Twitter Profile Photo

This is an AMAZING opportunity to join as early as it gets an A+ team working on some of the most critical problems at the intersection of neurobiology and neuroengineering.

PsyMed Ventures (@psymedventures) 's Twitter Profile Photo

NEW EPISODE: “Transforming Skin Cells into Neurons to Treat Alzheimer’s” with Brendon Boot of Skin2Neuron. Link here: businesstrip.fm/podcast/episod…

Matias Serebrinsky (@matisere) 's Twitter Profile Photo

Congrats to the Gilgamesh Pharmaceuticals team! Grateful to have had the opportunity to invest and support Gilgamesh personally and through PsyMed Ventures. This is also a huge win for the ecosystem. It's a validation that psychedelic therapeutics will have a place in the future